This series on Indications for Alloplastic TMJ Replacement in Maxillofacial Surgery – an evidence-based review of the literature is edited by Dr. Louis G Mercuri, from Rush University Medical Center, Chicago, IL, USA.
Louis G Mercuri
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA
Dr. Mercuri is a Cum Laude graduate of Georgetown University School of Dentistry, Washington, DC and received his Certification and Master of Science degree in Oral and Maxillofacial Surgery from the University of Illinois Chicago Medical Center. Dr. Mercuri is a Life Member of the American Association of Oral and Maxillofacial Surgeons, a Retired Diplomate of the American Board of Oral and Maxillofacial Surgeons, the recipient of the 2009 Oral and Maxillofacial Foundation Research Recognition Award, the 2010 William J. Gies Foundation Distinguished Achievement Award in Oral and Maxillofacial Surgery. In 2011 he was awarded an Honorary Fellowship in the Royal College of Surgeons of England Faculty of Dental Surgery. In 2020, he received the inaugural ASTMJS Louis G. Mercuri Lifetime Achievement Award from the American Society of TMJ Surgeons.
Dr. Mercuri is presently Visiting Professor in the Department of Orthopaedic Surgery at Rush University Medical Center, Chicago, President of the Institute of Biomaterials, Tribocorrosion, Nanotechnology and Regenerative Medicine at the University of Illinois Chicago and a Clinical Consultant for TMJ Concepts, Ventura California.
- Arthritic Diseases
- Benign Neoplasia
- Failed Autogenous Tissues
- Failed Alloplastic Devices
- Developmental and Craniofacial Anomalies
- Skeletally Immature Patients
- Obstructive Sleep Apnea
- Condylar Resorption
The series “Indications for Alloplastic TMJ Replacement in Maxillofacial Surgery – an evidence-based review of the literature” was commissioned by the editorial office, Frontiers of Oral and Maxillofacial Medicine without any sponsorship or funding. Louis G Mercuri is serving as the unpaid Guest Editor for the series.